RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+4.61%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$870M
AUM Growth
-$103M
(-11%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-12.27%
Top 10 Holdings %
Top 10 Hldgs %
34.33%
Holding
104
New
12
Increased
20
Reduced
55
Closed
10
Top Buys
| 1 |
Glaukos
GKOS
|
$23M |
| 2 |
Bristol-Myers Squibb
BMY
|
$19.8M |
| 3 |
Elevance Health
ELV
|
$11.2M |
| 4 |
Molina Healthcare
MOH
|
$11.2M |
| 5 |
DexCom
DXCM
|
$10.6M |
Top Sells
| 1 |
Merck
MRK
|
$21.9M |
| 2 |
Inspire Medical Systems
INSP
|
$21.4M |
| 3 |
Cigna
CI
|
$16.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$14.7M |
| 5 |
Boston Scientific
BSX
|
$14.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Bio-Techne
TECH
$8.3B
| – | – |
-3,000
| Closed | -$216K |
|
102
Transmedics
TMDX
$3.65B
| – | – |
-38,000
| Closed | -$2.37M |
|
103
Universal Health Services
UHS
$11.6B
| – | – |
-30,900
| Closed | -$5.54M |
|
|
ITCI
104
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-176,000
| Closed | -$14.7M |
|